Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study.
Guanxiong LiuDuo ZhuQuansheng HeChuren ZhouLi HeZhengran LiZaibo JiangMingsheng HuangBoyang ChangChun WuPublished in: Journal of hepatocellular carcinoma (2024)
Combining HAIC with LEN and PD-1 inhibitors proves to be both effective and safe in managing APS in HCC with PVTT, potentially improving patient survival.